BYLVAY
Identification of Bylvay
| No description |
Google image searchProduct monograph
Active ingredient
odevixibat, 400 MCG
DIN: 02542676
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: MEDISON PHARMA CANADA INC.
Date: 07-FEB-2024
ATC:
- A05 — BILE AND LIVER THERAPY (ATC, ATC/DDD, )
- A05A — BILE THERAPY (ATC, ATC/DDD)
- A05AX — Other drugs for bile therapy (ATC, ATC/DDD)
- A05AX05 — ODEVIXIBAT (ATC/DDD)
Reference brand drug: Bylvay
